All news

Cognizant (CTSH) Extends Strategic Partnership with Gilead Sciences for Five More Years

Alpha Vantage · GuruFocus · · AI-summarised by FinFlash

Cognizant has extended its strategic partnership with Gilead Sciences for another five years, focusing on enhancing DevOps capabilities and integrating AI tools. The article highlights Cognizant's strong financial health, including an attractive dividend yield of 2.26% and a GF Score™ of 90, suggesting it is significantly undervalued. While insiders have shown net selling, institutional guru ownership indicates confidence in the company's long-term prospects.

Read original source

CTSH company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.